BIO 2016 video interview: Merck counsel on biosimilar issues


Casey Thampoe, managing IP counsel for biologics and vaccines at Merck & Co, was one of a panel of speakers on a session outlining the biosimilars situation in the US.

Speaking to LSIPR, Thampoe provided an overview of the session and what was discussed.

 You can read our report of the session here.

Merck & Co, BPCIA, BIO 2016, 2016 BIO International Convention, Casey Thampoe, biosimilars